Julie Ma
About Julie Ma
Julie Ma serves as the Vice President of Biometrics at AlloVir, a position she has held since 2022. With extensive experience in biostatistics, she has previously worked in leadership roles at Assembly Biosciences and Gilead Sciences.
Current Role at AlloVir
Julie Ma serves as the Vice President of Biometrics at AlloVir, a position she has held since 2022. In this role, she oversees the biometrics function, which includes biostatistics, data management, and statistical programming. Her leadership contributes to the development of innovative therapies aimed at addressing viral infections.
Previous Experience at Assembly Biosciences
Before joining AlloVir, Julie Ma worked at Assembly Biosciences, Inc. as the Vice President of Biometrics from 2020 to 2022. In this capacity, she was responsible for guiding the biometrics team and ensuring the integrity of data used in clinical trials, enhancing the company's research capabilities.
Career at Gilead Sciences
Julie Ma spent nine years at Gilead Sciences, where she held various positions in biostatistics, culminating in the role of Executive Director. Her tenure from 2011 to 2020 involved leading teams and projects that supported the development of critical therapies in the pharmaceutical industry.
Educational Background
Julie Ma earned her Doctor of Philosophy (PhD) in Biostatistics from Columbia University, where she studied from 1998 to 2001. Prior to that, she obtained a Master of Science (MS) in Computational Mathematics from the University of Minnesota Duluth. Her academic background provides a strong foundation for her expertise in biostatistics and data analysis.
Early Career at Merck and Amgen
Julie Ma began her career in biostatistics at Merck, where she worked as a Senior Biometrician from 2001 to 2006. She then transitioned to Amgen, serving as a Senior Manager in Biostatistics from 2006 to 2011. These roles contributed to her extensive experience in the pharmaceutical industry and her development as a leader in biometrics.